Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Synlogic (SYBX)
NASDAQ:SYBX
Synlogic (SYBX) Stock Price & Analysis
566 Followers
SYBX Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$1.55 - $10.64
Previous Close$1.8
Volume26.34K
Average Volume (3M)136.17K
Market Cap
$21.21M
Enterprise Value$5.75M
Total Cash (Recent Filing)$33.41M
Total Debt (Recent Filing)$18.20M
Price to Earnings (P/E)-0.2
Beta0.73
Next Earnings
May 09, 2024EPS Estimate
-$1.02Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-10.88
Shares Outstanding11,646,977
10 Day Avg. Volume31,882
30 Day Avg. Volume136,170
Standard Deviation0.23
R-Squared0.06
Alpha-0.05
Financial Highlights & Ratios
Price to Book (P/B)0.48
Price to Sales (P/S)17.77
Price to Cash Flow (P/CF)-0.90
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue8.12
Enterprise Value/Gross Profit4.87
Enterprise Value/Ebitda-0.18
Forecast
1Y Price Target
$1.00Price Target Upside-45.10% Downside
Rating ConsensusHold
Number of Analyst Covering3
Synlogic News
PremiumCompany Announcements
Synlogic Appoints James Flynn to Board Amidst Director Resignations
PremiumCompany Announcements
Synlogic Announces Top Executive Departures and Compensation Deals
PremiumCompany Announcements
Synlogic Enacts Shareholder Rights Plan for Equitable ControlRisk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
SYBX FAQ
What was Synlogic’s price range in the past 12 months?
Synlogic lowest stock price was $1.55 and its highest was $10.63 in the past 12 months.
What is Synlogic’s market cap?
Currently, no data Available
When is Synlogic’s upcoming earnings report date?
Synlogic’s upcoming earnings report date is May 09, 2024 which is in 16 days.
How were Synlogic’s earnings last quarter?
Synlogic released its earnings results on Mar 19, 2024. The company reported -$1.71 earnings per share for the quarter, missing the consensus estimate of -$0.933 by -$0.777.
Is Synlogic overvalued?
According to Wall Street analysts Synlogic’s price is currently Overvalued.
Does Synlogic pay dividends?
Synlogic does not currently pay dividends.
What is Synlogic’s EPS estimate?
Synlogic’s EPS estimate is -$1.02.
How many shares outstanding does Synlogic have?
Synlogic has 11,646,977 shares outstanding.
What happened to Synlogic’s price movement after its last earnings report?
Synlogic reported an EPS of -$1.71 in its last earnings report, missing expectations of -$0.933. Following the earnings report the stock price went down -6.316%.
Which hedge fund is a major shareholder of Synlogic?
Among the largest hedge funds holding Synlogic’s share is RA Capital Management. It holds Synlogic’s shares valued at N/A.
---
Synlogic Stock Smart Score
Not Ranked
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$1.00 (-45.10% Downside)
$1.00 (-45.10% Downside)
Blogger Sentiment
Bullish
SYBX Sentiment 100%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Decreased
By 307.9K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $968.8 over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.5%
Last 30 Days ▼ 8.0%
Last 30 Days ▼ 8.0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-82.46%
12-Months-Change
Fundamentals
Return on Equity
-91.46%
Trailing 12-Months
Asset Growth
-31.85%
Trailing 12-Months
Company Description
Synlogic
Synlogic, Inc. is a clinical-stage biopharmaceutical company, which engages in drug discovery and development of synthetic biotic medicines. It focuses on SYNB1020 and SYNB1618, which are orally administered and target hyperammonemia and phenylketonuria. It also works on SYNB1891, an intratumorally administered which treats cancer. The company was founded by Jim Collins and Tim Lu on August 28, 2017, and is headquartered in Cambridge, MA.
---
SYBX Stock 12 Months Forecast
Average Price Target
$1.00
▼(-45.10% Downside)
Technical Analysis
Sangamo Biosciences
―
BioMarin Pharmaceutical
―
Sarepta Therapeutics
―
Crispr Therapeutics AG
―
Best Analysts Covering SYBX
1 Year
1 Year Success Rate
0/1 ratings generated profit
1 Year Average Return
-41.90%
initiated a buy rating 4 months ago
Copying James Molloy's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -41.90% per trade.
---